Biovie (BIVI) Total Current Liabilities (2013 - 2026)
Biovie (BIVI) posted Total Current Liabilities of $1.7 million for Q1 2026, down 43.65% sequentially from $3.0 million in Q4 2025, and down 33.49% YoY from $2.5 million in Q1 2025.
Biovie (BIVI) Total Current Liabilities (2013 - 2026) Analysis & Trends
Biovie has reported Total Current Liabilities for 14 years, with the latest figure at $1.7 million in Q1 2026.
- Quarterly Total Current Liabilities fell 33.49% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 33.49% YoY) and the FY2025 annual result came in at $2.3 million, down 75.68% from the prior year.
- Total Current Liabilities fell to $1.7 million in Q1 2026 per BIVI's latest filing, from $3.0 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $16.0 million in Q1 2023 and troughed at $1.5 million in Q4 2024.
- A 5-year average of $7.0 million and a median of $4.3 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities surged 318.43% in 2022, then plunged 89.58% in 2024.
- Over 5 years, Total Current Liabilities stood at $7.8 million in 2022, then soared by 79.32% to $14.0 million in 2023, then slumped by 89.58% to $1.5 million in 2024, then soared by 106.31% to $3.0 million in 2025, then tumbled by 43.65% to $1.7 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.7 million, $3.0 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 630.93 Mn |
| 10 | Biovie | 13.77 Mn | 13.77 Mn | - | 3.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.80 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 6.84 Mn |
| Jun 30, 2024 | 9.35 Mn |
| Mar 31, 2024 | 12.48 Mn |
| Dec 31, 2023 | 13.98 Mn |
| Sep 30, 2023 | 13.21 Mn |
| Jun 30, 2023 | 14.49 Mn |
| Mar 31, 2023 | 16.00 Mn |
| Dec 31, 2022 | 7.80 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 4.36 Mn |
| Sep 30, 2021 | 1.26 Mn |